Online citations, reference lists, and bibliographies.

NHG-Standaard Fluor Vaginalis

H. Dekker, P. Böke, J. Gercama, J. G. Kardolus, S. F. Boukes
Published 2009 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
Tweede Nationale Studie naar ziekten en verrichtingen in de huisartspraktijk: klachten en aandoeningen in de bevolking en in de huisartspraktijk.
M. V. D. Linden (2004)
10.1136/sti.69.5.388
Effect of lactic acid suppositories compared with oral metronidazole and placebo in bacterial vaginosis: a randomised clinical trial.
A. Boeke (1993)
Efficacy of Intravaginal 0.75% Metronidazole Gel for the Treatment of Bacterial Vaginosis
S. Hillier (1993)
10.1016/0020-7292(89)90378-0
Clotrimazole treatment of recurrent and chronic candida vulvovaginitis
J. Sobel (1989)
10.1097/00002508-199703000-00006
Vulvar vestibulitis syndrome: a critical review.
S. Bergeron (1997)
Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream.
D. Ferris (1995)
10.1016/S0304-3959(00)00449-8
A randomized comparison of group cognitive–behavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis
S. Bergeron (2001)
10.1046/J.1365-2125.1997.00660.X
Is metronidazole teratogenic? A meta-analysis.
T. Caro-Patón (1997)
10.1111/j.1471-0528.1998.tb10094.x
A population based case‐control teratologic study of oral metronidazole treatment during pregnancy
A. Czeizel (1998)
10.1093/fampra/7.2.138
Predictors of Chlamydia trachomatis infection in women in general practice.
F. Bro (1990)
10.1056/NEJM198407053110101
Mucopurulent cervicitis--the ignored counterpart in women of urethritis in men.
R. Brunham (1984)
10.1111/j.1471-0528.2002.01142.x
Oral versus intra‐vaginal imidazole and triazole anti‐fungal agents for the treatment of uncomplicated vulvovaginal candidiasis (thrush): a systematic review
M. Watson (2002)
10.1016/S0002-9378(94)70278-0
Bacterial vaginosis: efficacy and safety of intravaginal metronidazole treatment.
C. Livengood (1994)
10.1056/NEJMOA020205
A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates.
S. Schrag (2002)
Single-dose 500-mg clotrimazole vaginal tablets compared with placebo in the treatment of Candida vaginitis.
F. Bro (1990)
10.1016/0002-9343(83)91112-9
Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations.
R. Amsel (1983)
Efficacy of Clindamycin Vaginal Cream Versus Oral Metronidazole in the Treatment of Bacterial Vaginosis
F. Fischbach (1993)
10.1016/S0277-9536(02)00092-8
The vaginitis monologues: women's experiences of vaginal complaints in a primary care setting.
A. Karasz (2003)
Vaginal symptoms of unknown aetiology: a study in Dutch general practice.
J. Dekker (1993)
10.1056/NEJMOA033114
Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.
J. Sobel (2004)
10.1258/095646203321043183
Relation between Gram-stain and clinical criteria for diagnosing bacterial vaginosis with special reference to Gram grade II evaluation.
D. Taylor-Robinson (2003)
10.1136/sti.70.2.124
The value of prophylactic (monthly) clotrimazole versus empiric self-treatment in recurrent vaginal candidiasis.
I. Fong (1994)
[Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population of Amsterdam. Il Over 90% participation and almost 5% prevalence].
J. van den Hoek (1999)
10.3109/02813438909103665
The diagnosis of candida vaginitis in general practice.
F. Bro (1989)
Vaginale afscheiding: wat zeggen vrouwen er zelf over?
W. Meijden (1985)
Van klacht naar diagnose : episodegegevens uit de huisartspraktijk
I. Okkes (1998)
Bacterial Vaginosis: Treatment With Topical Intravaginal Clindamycin Phosphate
C. Livengood (1990)
Differentiation of Gardnerella vaginalis, Candida albicans, and Trichomonas vaginalis infections of the vagina.
B. Reed (1989)
Recurrent vulvovaginal candidiasis.
C. Macneill (2001)
10.1016/S0002-9378(85)80003-X
Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis.
J. Sobel (1985)
10.1016/S0002-9343(99)00466-0
A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis.
W. Wiese (2000)
10.1001/JAMA.291.11.1368
Evaluation of vaginal complaints.
M. Anderson (2004)
10.1001/ARCHFAMI.9.7.647
Bacterial vaginosis and treatment of sexual partners.
M. Hamrick (2000)
10.1001/jama.1992.03490010094036
Comparison of different metronidazole therapeutic regimens for bacterial vaginosis. A meta-analysis.
V. I. Lugo-Miro (1992)
Damage to condoms caused by vaginally administered drug
Meyboom Rh (1995)
Systematische opsporing van infecties met chlamydia trachomatis bij mannen en vrouwen zonder klachten in de huisartspraktijk met behulp van per post verstuurde urinemonsters
I. V. Valkengoed (1999)
10.1136/bmj.38169.519653.EB
Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery
H. Kiss (2004)
10.1001/jama.1988.03410020073031
Cost-effectiveness of screening women at moderate risk for genital infections caused by Chlamydia trachomatis.
M. Nettleman (1988)
10.1258/095646202760159639
Facts and myths on recurrent vulvovaginal candidosis—a review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy
P. Mårdh (2002)
10.1097/00007611-199211000-00006
Clindamycin Vaginal Cream Versus Oral Metronidazole in the Treatment of Bacterial Vaginosis: A Prospective Double‐Blind Clinical Trial
F. Andres (1992)
10.1136/bmj.329.7462.374
Does screening reduce preterm births?
A. Alanen (2004)
Bacterial vaginosis in pregnancy and the risk of prematurity: a meta-analysis.
C. Flynn (1999)
10.1016/0002-9378(95)90567-7
Safety of metronidazole in pregnancy: a meta-analysis.
P. Burtin (1995)
10.1016/0020-7292(91)90849-Z
Microbiologic efficacy of intravaginal clindamycin cream for the treatment of bacterial vaginosis
S. Hillier (1990)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar